Information Provided By:
Fly News Breaks for February 22, 2018
Feb 22, 2018 | 10:16 EDT
Stifel analyst Michael Hoffman reiterated his Buy rating on Stericycle following the company's Q4 report, noting its sales beat and "slight" EPS miss. The company's conventional free cash flow "remains sound" with a five year CAGR forecast of over 10%, added Hoffman, who maintains his $90 price target on Stericycle shares, which are down 16.5% to $62.50 in early trading.
Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.